NOT-NS-25-003: Notice of Information: Technical Assistance Webinars for RFA-NS-25-024 Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Notice of Information: Technical Assistance Webinars for RFA-NS-25-024 “Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Notice Number:

NOT-NS-25-003

Key Dates

Release Date:

October 10, 2024

Related Announcements

September 26, 2024 - Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required). See Notice RFA-NS-25-024.

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The National Institute of Neurological Disorders and Stroke (NINDS) will be hosting pre-application, technical assistance webinars on Tuesday, October 29, from 1:30 PM – 2:30 PM (Eastern Time) and on Tuesday, December 3, from 2 PM – 3 PM (Eastern Time) for all potential applicants interested in the following Notice of Funding Opportunity (NOFO):

RFA-NS-25-024– Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

This NOFO aims to encourage grant applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products. These applications will target EA for intermediate size populations of patients living with ALS who are not eligible for ongoing clinical trials for the prevention, diagnosis, mitigation, treatment, or cure of ALS.

NIH program and review staff will provide an overview of RFA-NS-25-024, including objectives, application instructions, and review criteria and will be available to answer questions. Potential applicants who wish to join in the webinar must pre-register for the webinar using the link below.

We request that participants carefully review RFA-NS-25-024 prior to joining the webinar. Participation in the webinar is optional and is not required for the submission of an application.

Webinar Information

Topic: Technical Assistance Webinar: RFA-NS-25-024 - Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Dates/Times: Tuesday, Oct. 29, 2024 at 1:30 PM- 2:30 PM ET; and Tuesday, Dec. 3, 2024 at 2:00 PM- 3:00 PM ET

To join the webinar, please choose the date you would like to attend and preregister with the following links:

Oct. 29, 2024: https://nih.zoomgov.com/webinar/register/WN_ZEDRfmGLQd6VNE4cZ7qPPA

Dec. 3, 2024: https://nih.zoomgov.com/webinar/register/WN_1PB3RyxBR06k5iRH6hFPHA

Participants requiring sign language interpretation and/or other reasonable accommodations should contact elio.peraza@nih.gov at least 5 days prior to the event.

Participants can submit questions in advance to Elio Peraza, elio.peraza@nih.gov, through the pre-registration link, or during the webinar in the Q&A box.

Event registration for both sessions, frequently asked questions (FAQs), recordings of the webinars (available after the event), and additional information may be found here:

Webinar #1: Oct. 29: https://www.ninds.nih.gov/news-events/events/informational-webinar-applicants-ninds-als-expanded-access-u01-0
Webinar #2: Dec. 3: https://www.ninds.nih.gov/news-events/events/informational-webinar-applicants-ninds-als-expanded-access-u01-1

Inquiries

Please direct all inquiries to:

Elio Peraza
National Institute of Neurological Disorders and Stroke (NINDS)
Email: elio.peraza@nih.gov